Additionally, women experienced more severe heart failure symptoms compared to men at baseline
But the magnitude of those results differs substantially
Whether youre starting your weight loss journey or managing side effects along the way, were here to support you
Leadership addressed immediately, and the site received FDA approval for full production for market in August 2023, Novo Nordisks Bennett says
It belongs to the GLP-1 receptor agonist class of medications, which work by mimicking a natural hormone that regulates blood sugar and appetite
Our study included approximately 170,000 participants in each group after propensity score matching and demonstrated that semaglutide was associated with a reduced risk of all-cause death, acute myocardial infarction, stroke, and acute heart failure compared to dulaglutide